Washington, DC
Morgantown, WV
Washington, DC
Morgantown, WV
Please, provide us with your contact information and let us know in which of our products you are interested.
You can also reach out directly to:
Kimberly Brown at
[email protected]
Licensed Wholesale Drug Distributor
Washington, DC | Morgantown, WV
Innova Pharmaceuticals © 2023 All Rights Reserved
President, Innova Pharmaceuticals
Innova-Blue Bio USA
Kimberly Brown is the President of Innova Pharmaceuticals, where she leads the company’s tactical operations, ensuring
alignment with its strategic goals. Her leadership emphasizes expanding drug import opportunities and advancing
manufacturing initiatives.
With extensive executive experience, Kimberly has a strong background in real estate development, public-private
partnerships, and managing complex commercial projects. She oversees multiple businesses in Fort Lauderdale and
Washington, DC, specializing in market development, financial structuring, and biotech startups.
Since 2018, Kimberly has also served as President of IP SecureTech, LLC, where she has directed large-scale national and international projects in industrial development, data centers, and biotech ventures. Her diverse expertise includes managing the Boca Regional Hospital food services program,
overseeing staffing, budgeting, and forecasting responsibilities.
Kimberly’s proven track record in leading cross-industry initiatives and executing large-scale projects positions her as a key driver of Innova Pharmaceuticals’ mission and long-term success.
Company President
CEO – Innova Pharmaceuticals
Innova-Blue Bio USA
Chris McElvany, a seasoned serial entrepreneur and private equity investor, serves as CEO of Innova Pharmaceuticals,
where he focused on addressing drug shortages, decentralizing pharmaceutical supply chains, and delivering innovative healthcare solutions.
With decades of leadership experience, McElvany has co-founded and scaled successful businesses, including Lucy
Scientific Discovery, which IPO’d at $65.4 million, and OrganaBrands, sold into SLANG Worldwide for $226 million. He also brings expertise from board roles with NASDAQ and Canadian Securities Exchange-listed
companies, excelling in regulatory compliance and strategic growth.
At Lucy Scientific Discovery, McElvany secured licenses for Schedule 1-3 drugs and led the manufacturing and global export of regulated APIs, showcasing his ability to navigate complex regulatory frameworks. His ventures span diverse
industries, including biotechnology, food and beverage, and advanced manufacturing.
Under his leadership, Innova Pharmaceuticals is driving innovation in drug manufacturing and development, positioning itself as a leader in tackling the pharmaceutical industry’s most pressing challenges.
Senior Director, International Strategy and Trade
Innova-Blue Bio USA
William Steuer, a retired Senior Foreign Service officer from the U.S. Department of State, brings decades of expertise in
diplomacy, cross-cultural engagement, and high-stakes negotiations to Innova Pharmaceuticals. As a former Counselor of Embassy, he held leadership roles equivalent to CEO and COO at major U.S. embassies in Africa, Central Asia, and the Middle East.
With a vast network spanning federal agencies and international business, Will provides critical insights into foreign investment strategies, geopolitical dynamics, negotiation tactics, and cross-border operations for Innova’s International Trade Office. Fluent in English and French, his linguistic skills and global perspective enhance his ability to build international partnerships.
Holding an active federal security clearance, Will’s expertise bolsters Innova’s mission to thrive in the interconnected pharmaceutical industry.
CEO, BlueBio Pte Ltd. Asia and
Innova-Blue Bio USA
Dr. Huy Phung leads BlueBio USA and BlueBio Asia with 27 years of expertise in pharmaceutical supply chains and formula design. Throughout his career, he has been dedicated to upholding the highest standards in quality assurance, regulatory compliance, and product development across the pharmaceutical and medical device industries.
Dr. Phung’s extensive background includes leadership roles in clinical biochemistry, toxicology, and R&D, with academic affiliations at MIT, Princeton University, and Ho Chi Minh University. He has driven groundbreaking initiatives in nanoparticle and biochemistry development, collaborating with global pharmaceutical companies and manufacturers.
Under his leadership, BlueBio focuses on:
Dr. Phung’s visionary leadership ensures that BlueBio continues to be a leader in quality and innovation within the pharmaceutical and biopharmaceutical industries.
CEO, EcomBlue LLC
Innova-Blue Bio USA
Mark Depew is the CEO of EcomBlue LLC, a forward-thinking company dedicated to providing affordable pharmaceuticals directly to consumers. With over 35 years of experience in startups, Mark specializes in capital raising, strategic investments, and crafting scalable business strategies. EcomBlue LLC operates across several key areas of global commerce, including:
Under Mark’s leadership, EcomBlue leverages its expertise in logistics, finance, and regulatory compliance to deliver innovative, cost-effective solutions in the pharmaceutical and healthcare industries.
Senior Executive, Biopharmaceutical Strategy
BlueBio Asia and Innova-Blue Bio USA
Minh Tran, a visionary leader with over 30 years of experience in the biopharmaceutical and biologics industries. Minh has a proven track record in building high-performing
organizations and driving sustainable business growth. He specializes in facility design, process optimization, manufacturing operations, and advancing Biopharma 4.0 through automation, data analytics, and process analytical technologies (PAT).
As the former Global Head of Commercial for Automation, PAT, and Digital Solutions at Merck KGaA, Minh led digital transformation strategies and successfully launched a $250
million biopharmaceutical manufacturing facility supporting contract manufacturing of drug substance and drug products for the global regulated markets. His expertise spans Asia-Pacific markets, global operations, and managing complex, high-impact projects for leading biopharma organizations.
Currently, at BlueBio Asia, Minh focuses on enhancing pharmaceutical manufacturing capabilities across Asia, emphasizing international strategy, business development, contract negotiation, and strategic partnerships. Known for
mentoring high-performance teams and negotiating multi-million-dollar contracts, Minh is a trusted thought leader committed to innovation and operational excellence.
Aligned with Innova-BlueBio’s mission, Minh is dedicated to addressing global pharmaceutical challenges and driving transformative changes in the biopharma sector.
